标题
ENDOPHTHALMITIS ASSOCIATED WITH INTRAVITREAL INJECTIONS
作者
关键词
-
出版物
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Volume 34, Issue 1, Pages 18-23
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2013-12-20
DOI
10.1097/iae.0000000000000008
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Update on Risk of Endophthalmitis After Intravitreal Drug Injections and Potential Impact of Elimination of Topical Antibiotics
- (2012) Cynthia R. Stockdale ARCHIVES OF OPHTHALMOLOGY
- Changes in Antibiotic Resistance Patterns of Conjunctival Flora Due to Repeated Use of Topical Antibiotics after Intravitreal Injection
- (2012) Eugene Milder et al. OPHTHALMOLOGY
- Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
- (2012) Daniel F. Martin et al. OPHTHALMOLOGY
- Incidence of Endophthalmitis and Use of Antibiotic Prophylaxis after Intravitreal Injections
- (2012) Crystal S.Y. Cheung et al. OPHTHALMOLOGY
- Antimicrobial Resistance Profiles of Ocular and Nasal Flora in Patients Undergoing Intravitreal Injections
- (2011) Chrisfouad R. Alabiad et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Bacterial Dispersal Associated With Speech in the Setting of Intravitreous Injections
- (2011) Joanne C. Wen ARCHIVES OF OPHTHALMOLOGY
- Antimicrobial Resistance and Ophthalmic Antibiotics
- (2011) Stephen J. Kim ARCHIVES OF OPHTHALMOLOGY
- Myositis Ossificans
- (2011) Deborah A. Martin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
- (2011) Chirag P. Shah et al. OPHTHALMOLOGY
- PROPHYLACTIC ANTIBIOTIC USE AFTER INTRAVITREAL INJECTION
- (2011) Shabari S Bhatt et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS
- (2011) Andrew A Moshfeghi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Survey of Intravitreal Injection Techniques Among Retinal Specialists in the United States
- (2010) Amy E. Green-Simms et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Antibiotic Susceptibility Patterns of Ocular Bacterial Flora in Patients Undergoing Intravitreal Injections
- (2010) Jason M. Moss et al. OPHTHALMOLOGY
- DELAYED-ONSET BLEB-ASSOCIATED ENDOPHTHALMITIS (1996–2008)
- (2010) Theodore Leng et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Risk of Endophthalmitis After Intravitreal Drug Injection When Topical Antibiotics Are Not Required
- (2009) Abdhish R. Bhavsar ARCHIVES OF OPHTHALMOLOGY
- Incidence and management of acute endophthalmitis after intravitreal bevacizumab (Avastin) injection
- (2009) O Artunay et al. EYE
- INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS
- (2009) TERESA DIAGO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office Setting
- (2008) Suman Pilli et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION
- (2008) JOHN O. MASON et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
- (2008) DAVID R. FINTAK et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started